Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trustworthy and explainable AI for drug discovery.

Expert opinion on drug discovery·2026
Same author

Unlocking SLC6A15 (B<sup>0</sup>AT2): A Dual-Platform Approach To Accelerate Drug Discovery for Neuropsychiatric Disorders.

Analytical chemistry·2026
Same author

Response to letter regarding "AI‑based analysis of label‑free live‑cell imaging of T‑cell-mediated tumor killing".

SLAS discovery : advancing life sciences R & D·2026
Same author

AI-based analysis of label-free live cell imaging of T-cell mediated tumor killing assay enables competitive and robust hit calling.

SLAS discovery : advancing life sciences R & D·2026
Same author

PCIM: Learning pixel attributions via pixel-wise channel isolation mixing in high content imaging.

SLAS discovery : advancing life sciences R & D·2025
Same author

Advancing large-molecule discovery with a unified digital platform for data analysis and workflow management.

mAbs·2025
Same journal

A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.

SLAS discovery : advancing life sciences R & D·2026
Same journal

Tumor-versus-nonmalignant quantitative drug sensitivity profiling identifies capivasertib as a selective therapeutic candidate for nasopharyngeal carcinoma.

SLAS discovery : advancing life sciences R & D·2026
Same journal

ADCs for colorectal carcinoma: decoding clinical evidence for molecular design innovation.

SLAS discovery : advancing life sciences R & D·2026
Same journal

CellVision: A deep learning based image analysis platform to accelerate immuno-plaque assay data processing for dengue vaccine development.

SLAS discovery : advancing life sciences R & D·2026
Same journal

Use t tests to analyze counts of cells in two states.

SLAS discovery : advancing life sciences R & D·2026
Same journal

In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion.

SLAS discovery : advancing life sciences R & D·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2025

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
11:00

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS

Published on: May 20, 2013

22.5K

A robust CETSA data analysis automation workflow for routine screening.

Juan Daniel Florez Weidinger1, Moritz Pfreundschuh1, Diana Zörb2

  • 1Genedata AG, Basel, Switzerland.

SLAS Discovery : Advancing Life Sciences R & D
|July 5, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces an automated data analysis workflow for Cellular Thermal Shift Assay (CETSA) to enhance high-throughput screening. The new method streamlines protein-ligand interaction analysis, improving efficiency and reliability in drug discovery.

Keywords:
Assay technologyData analysisDrug discoveryLaboratory automation

More Related Videos

Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques
07:52

Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques

Published on: December 1, 2023

1.0K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

801

Related Experiment Videos

Last Updated: Jun 21, 2025

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS
11:00

Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry UPLC-HRMS

Published on: May 20, 2013

22.5K
Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques
07:52

Author Spotlight: Enhancing Cryo-Electron Microscopy by Automated Data Collection and Analysis Techniques

Published on: December 1, 2023

1.0K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

801

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Discovery

Background:

  • Cellular Thermal Shift Assay (CETSA) is crucial for studying protein-ligand interactions in cells.
  • CETSA provides insights into binding affinity and specificity of small and large molecules.
  • Current data analysis and quality control for CETSA are laborious, limiting high-throughput screening.

Purpose of the Study:

  • To develop a scalable and robust data analysis workflow for integrating CETSA into routine high-throughput screening (HT-CETSA).
  • To automate data analysis and quality control processes for CETSA experiments.

Main Methods:

  • Introduction of a novel, automated data analysis workflow for CETSA.
  • Incorporation of automated quality control (QC) measures, including outlier detection, sample and plate QC, and result triage.
  • Validation of the workflow's robustness against experimental artifacts and assessment of scaling effects.

Main Results:

  • The automated workflow enables scalable and robust data analysis for HT-CETSA.
  • The workflow effectively automates data processing, reducing manual effort and potential errors.
  • Demonstrated robustness against common experimental artifacts and analyzed scaling effects.

Conclusions:

  • The developed workflow significantly enhances the throughput and reliability of CETSA for drug discovery.
  • Automation of data analysis and QC is key to integrating CETSA into routine high-throughput screening.
  • This approach facilitates more efficient and accurate assessment of protein-ligand interactions.